Drug Trial Radar · NCT06662383
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Last checked: Nov 20, 2026Latest source record: Jul 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Nov 1, 2024
Primary completion
Nov 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study will last about 89 weeks.
Conditions
- Obesity
Interventions
RetatrutideDrug
Administered SC
TirzepatideDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, Week 80
Locations
65 sites in 5 countries. Site status is shown where the registry gives one.
Medical Advancement Centers of Arizona
Tempe, Arizona
Mary & Dick Allen Diabetes Center
Newport Beach, California
Artemis Institute for Clinical Research
San Diego, California
Encompass Clinical Research
Spring Valley, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Lynn Institute of Denver
Aurora, Colorado
Bridgeport Hospital
Bridgeport, Connecticut
Yale University School of Medicine
New Haven, Connecticut
Encore Medical Research
Hollywood, Florida
Suncoast Research Group
Miami, Florida
Onhealth Research Center
Miami, Florida
Precision Clinical Research
Sunrise, Florida
Einstein Clinical Research
Vero Beach, Florida
ClinCept Clinical Research - MH
Columbus, Georgia
Northeast Georgia Medical Center
Gainesville, Georgia
Pivotal Research Solutions
Stonecrest, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Northwestern University
Chicago, Illinois
Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Great Lakes Research Group, Inc.
Bay City, Michigan
Great Lakes Research Institute
Southfield, Michigan
StudyMetrix Research
City of Saint Peters, Missouri
Las Vegas Endocrinology
Henderson, Nevada
Albany Medical College, Division of Community Endocrinology
Albany, New York
New York Gastroenterology Associates
New York, New York
Westchester Medical Center
Valhalla, New York
PharmQuest Life Sciences, LLC
Greensboro, North Carolina
Monroe Biomedical Research
Monroe, North Carolina
Accellacare - Wilmington
Wilmington, North Carolina
Lillestol Research
Fargo, North Dakota
PriMED Clinical Research
Dayton, Ohio
Tribe Clinical Research, LLC
Greenville, South Carolina
WR-Clinsearch, LLC
Chattanooga, Tennessee
Headlands Horizons LLC
Brownsville, Texas
Next Level Urgent Care
Houston, Texas
Houston Research Institute
Houston, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Chrysalis Clinical Research
St. George, Utah
Charlottesville Medical Research
Charlottesville, Virginia
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.